A Securities Fraud Class Action Lawsuit Has Been Filed Against Affymax, Inc., Shareholders Are Encouraged to Contact Holzer

  A Securities Fraud Class Action Lawsuit Has Been Filed Against Affymax,
  Inc., Shareholders Are Encouraged to Contact Holzer Holzer & Fistel, LLC

Business Wire

ATLANTA -- February 28, 2013

A class action lawsuit has been filed on behalf of investors who purchased
common stock of Affymax, Inc. (“Affymax” or the “Company”) (NASDAQ: AFFY)
between December 8, 2011 and February 22, 2013 (“Class Period”). The lawsuit,
which was filed in the United States District Court for the Northern District
of California, alleges Affymax issued false and misleading statements to
investors during the Class Period by failing to adequately disclose: (1) that
the Company’s FY 2012 financial guidance was materially overstated; (2) that
reported sales of its primary drug product were not sustainable; and (3) that
the defendants were materially overstating sales and understating the
potential liabilities related to its primary drug product, including refunds
and potential liability to injured patients.

If you purchased Affymax common stock between December 8, 2011 and February
22, 2013 and suffered a net loss on those purchases, you have the legal right
to petition the Court to be appointed a “lead plaintiff.” A lead plaintiff is
a representative party that acts on behalf of other class members in directing
the litigation. Any such request must satisfy certain criteria and be made no
later than April 29, 2013. Any member of the purported class may move the
Court to serve as lead plaintiff through counsel of their choice, or may
choose to do nothing and remain an absent class member.

Holzer Holzer & Fistel, LLC is also investigating whether the allegations
contained in the class action complaint also give rise to separate, additional
claims against the Board of Directors for breaches of fiduciary duty, which
could be enforced on behalf of the Company through shareholder derivative
litigation.

If you purchased Affymax common stock between December 8, 2011 and February
22, 2013 and suffered large losses, or if you presently own Affymax common
stock that was purchased and held continuously since at least December 8,
2011, you may contact Michael I. Fistel, Jr., Esq. (mfistel@holzerlaw.com) or
William Stone, Esq. (wstone@holzerlaw.com) by email or via toll-free telephone
at (888) 508-6832 to discuss your legal rights.

Holzer Holzer & Fistel, LLC dedicates its practice to vigorous representation
of shareholders and investors in litigation nationwide, including shareholder
class action and derivative litigation. More information about the firm is
available through its website, www.holzerlaw.com and upon request from the
firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this
promotional communication, and Michael I. Fistel, Jr. is the attorney
responsible for its content.

Contact:

Holzer Holzer & Fistel, LLC
Michael I. Fistel, Jr., Esq., 888-508-6832 (toll-free)
mfistel@holzerlaw.com
or
William Stone, Esq., 888-508-6832 (toll-free)
wstone@holzerlaw.com
 
Press spacebar to pause and continue. Press esc to stop.